For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts
Blog
This week in health care policy: September 28 – October 2, 2026
Drug pricing CMS finalizes GLOBE pilot. On September 30, CMS finalized the Global Benchmark for Efficient Drug Pricing model, a…
Blog
This week in health care policy: September 21–25, 2026
Innovation watch FDA approves the first treatment for Sanfilippo syndrome. On September 17, the FDA approved Ultragenyx’s Fayuvi, a one-time…
Blog
How The No Surprises Act worsened the problem of surprise bills
Next week, Sen. Bill Cassidy (R-LA) will convene a roundtable to discuss adjustments to the 2020 No Surprises Act, which has come under…
Search Posts
Newsletter
The Competitive Enterprise Institute Daily Update
Issues in the News 1. CONGRESS The House of Representative approves legislation requiring the government to negotiate lower…
Op-Eds
The High Cost of Low Price
Should free market advocates oppose a plan aimed at lowering prescription drug costs? Generally, no. But, when such a plan involves the flexing…
Newsletter
The Competitive Enterprise Institute Daily Update
Issues in the News 1. CONGRESS New Democratic congressmen warn Speaker Pelosi to stick to a politically moderate…
Op-Eds
Eco-Intimidation Bypasses Scientific Debate
Junk science traditionally has been pretty much of an in-your-face phenomenon. Activist-generated scary headlines that are followed by a hysterical rush to adopt new…
Letters
We oppose negotiations on Medicare Part D drug prices
We are deeply concerned about proposed legislation that would lead to negotiation of pharmaceutical prices by the federal government for the new Medicare Part…
Study
A Free Market Agenda for the 110th Congress
Washington, D.C., January 10, 2007—Today the Competitive Enterprise Institute releases its policy recommendations for the new leadership on Capitol Hill: This Liberal Congress Went to…